VANCOUVER, BC / ACCESS Newswire / September 8, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
SANTA CLARA, Calif., Sept. 3, 2026 /PRNewswire/ -- Anatomage Inc., a leader in medical visualization and education technology, today announced...
FAIRFAX, Va., Sept. 2, 2026 /PRNewswire/ -- Knowesis, a mid-sized government contractor with two decades history supporting Defense Health Agency...
New program combines brain science, mental health and spiritual principles to help churches build healthier communitiesCOSTA MESA, Calif., Sept. 2,...
Complimentary Dine & Learn for Strategic Care Operators Not Yet Using SensiPALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- WHAT:The...
New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single,...
20th Annual Research Grant Symposium in Louisville anchors month of activities as Foundation awards record $650,000 to advance brain aneurysm...
Gundry MD Vital Reds Reviews Highlight Energy, Digestion & Metabolism SupportLOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- As more consumers...
American Academy of Neurology launches new public websiteMINNEAPOLIS, Aug. 28, 2026 /PRNewswire/ -- The American Academy of Neurology (AAN) has launched BrainHealth.com,...
NORTHAMPTON, MA / ACCESS Newswire / August 27, 2026 / When a real patient arrived during a stroke-response training exercise,...
Designed to help people with hearing loss experience more natural and effortless listeningSOMERSET, N.J., Aug. 24, 2026 /PRNewswire/ -- HearingLife,...
Designed to help people with hearing loss experience more natural and effortless listeningSOMERSET, N.J., Aug. 24, 2026 /PRNewswire/ -- HearingLife,...
Memodyne's Supplement Facts panel details Beta-Alanine, Calcium, and serving amounts behind its 30-capsule focus, clarity, energy, and memory formula.Ogden, UT,...
Teffer brings firsthand experience shaping and evaluating early ARPA-H research concepts, alongside a decade of federal biomedical R&D advisory work.HOUSTON,...
FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical packages; IND...
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™...
Collaboration looks to explore the use of Darmiyan's FDA De Novo authorized BrainSee® imaging platform, authorized for predicting risk of...
Positive DRDC findings support the next phase for bucillamine as Revive plans to pursue government-backed development opportunities, expand intellectual property...
COVINGTON, Ky., Aug. 18, 2026 /PRNewswire/ -- NeuroQuant ® PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET...
SHELTON, CT / ACCESS Newswire / August 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...